Skip to main content
. 2022 May 30;12:866284. doi: 10.3389/fonc.2022.866284

Table 3.

Scores of the domains and overall assessment of the guidelines according to the AGREE II instrument.

Title of Guideline Domains (%) Overall Quality Degree of Recommendation ICC
Scope and Purpose Stakeholder Involvement Rigor of Development Clarity and Presentation Applicability Editorial Independence Average
NICE (CG81) (42) 100 100 92.2 88.9 91.7 89.6 93.73 High R 0.995
NICE (NG101) (28) 100 100 92.7 88.9 91.7 89.6 93.82 High R 0.993
Barnadas, Algara (37) 70.8 25.0 50.0 31.9 12.5 70.8 43.50 Low NR 0.989
St. Gallen International
Consensus (38)
69.4 61.1 19.8 38.8 19.7 62.5 45.22 Moderate RM 0.980
ESMO (EBC) 2019
(39)
73.6 66.7 44.8 41.7 45.8 66.7 56.55 Moderate RM 0.970
ESO-ESMO (ABC5) 2020 (40) 87.5 70.8 42.7 79.2 55.2 68.8 67.37 Moderate RM 0.956
ESO-ESMO (BCY4) 2020 (43) 83.3 72.2 63.5 69.4 53.1 68.8 68.38 Moderate RM 0.973
APTA guideline (41) 95.8 68.1 79.2 81.9 30.2 68.8 70.67 Moderate RM 0.993
SEOM 2018 (27) 69.4 36.1 18.2 47.2 12.5 33.3 36.12 Low NR 0.986
SIO guideline (30) 97.2 76.4 89.6 97.2 77.1 91.7 88.20 High R 0.983
ONS guideline (26) 88.9 88.9 77.1 83.3 77.1 91.7 84.50 High R 0.991
Reese, Weis (44) 83.3 83.3 53.1 44.4 49.0 66.7 63.30 Moderate RM 0.985
ACS-ASCO guideline
(45)
93.1 93.1 98.0 87.5 83.3 91.7 91.12 High R 0.992
Sisler, Chaput (29) 72.2 58.3 51.6 45.8 15.6 50.0 48.92 Moderate RM 0.994
Average 84.61 71.43 62.32 66.15 51.04 72.19 67.96 0.980

ICC, intraclass correlation coefficient; NICE, National Institute for Health and Care Excellence; R, recommended; NR, not recommended; RM, recommended with modifications; ESMO, European Society for Medical Oncology; EBC, early breast cancer; ESO, European School of Oncology; ABC, advanced breast cancer; APTA, American Physical Therapy Association; SEOM, bSociodad Española de Oncolgía Médica; SIO, Society of Interventional Oncology; ONS, Oncology Nursing Society; ACS, American Cancer Society; ASCO, American Society of Clinical Oncology.